Merck Provides Update on REVEAL Outcomes Study of Anacetrapib

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. RH
3. SPCX
4. USO
5. BBW
6. RKLB
7. NDAQ
8. ELVN
9. NVDA
10. FCPT

Go back to Merck Provides Update on REVEAL Outcomes Study of Anacetrapib
Merck & Co. (NYSE: MRK) Delayed: 120.76 --0 (-0%)
Previous Close $120.76    52 Week High $65.46 
Open $120.76    52 Week Low $47.97 
Day High $120.76    P/E 82.15 
Day Low $120.76    EPS $1.47 
Volume 749